Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulcrum, adidas, and Spirit and Encourages Investors to Contact the Firm
19 mai 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
DEADLINE ALERT for ADDYY/ADDDF, FULC, TDS, and SPR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
19 mai 2023 11h21 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, May 19, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FULC
18 mai 2023 13h50 HE
|
The Rosen Law Firm PA
NEW YORK, May 18, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc., (NASDAQ: FULC) between March 3, 2022...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Edgio, Fulcrum, and adidas and Encourages Investors to Contact the Firm
14 mai 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 14, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FULC
13 mai 2023 16h10 HE
|
The Rosen Law Firm PA
NEW YORK, May 13, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc., (NASDAQ: FULC) between March 3,...
DEADLINE ALERT for ADDYY/ADDDF, FULC, TDS, and SPR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
12 mai 2023 11h09 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, May 12, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulcrum, adidas, and Spirit and Encourages Investors to Contact the Firm
08 mai 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc. (NASDAQ: FULC)
08 mai 2023 08h15 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulcrum, and adidas and Encourages Investors to Contact the Firm
03 mai 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Fulcrum Therapeutics, Inc. (NASDAQ: FULC)
03 mai 2023 01h45 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...